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Klebsiella pneumoniae and Haemophilus influenzae are two common pathogens associated with respiratory tract infections.
The identification of these pathogens using conventional molecular diagnostic tests requires trained personnel, cold-chain
transportation, and storage-dependance, which does not render them user-friendly. The aim of this study was to develop a
thermostabilized, cold-chain-free, one-step multiplex PCR for simultaneous detection of K. pneumoniae and H. influenzae. The
multiplex PCR assay was designed to amplify the php gene of K. pneumoniae (202 bp) and p6 gene of H. influenzae (582 bp).
In addition, the specific primer to amplify glm gene of Helicobacter pylori (105 bp) was included as an internal amplification
control. Subsequently, the designed primers and all PCR reagents were thermostabilized by lyophilization. The stability of the
thermostabilized PCR was evaluated using the Q10 method. The sensitivity and specificity of performances for thermostabilized
PCR were evaluated using 127 clinical isolates and were found to be 100% sensitive and specific.The thermostabilized PCRmix was
found to be stable for 30 days and the Q10 accelerated stability was found to be 3.02 months. A cold-chain-free, PCR assay for easy,
rapid, and simultaneous detection of K. pneumoniae and H. influenzae was successfully developed in this study.
1. Introduction
Klebsiella pneumoniae and Haemophilus influenzae are two
common pathogens associated with respiratory tract infec-
tions. Rapid detection and identification of these two
pathogens are important so that appropriate and early antimi-
crobial therapy can be provided. The definitive identification
of bacterial respiratory pathogens ismade through the culture
method. However, the major drawbacks of conventional
culture methods are that it is time consuming and laborious
and may take at least 48 hours for organism identification.
Furthermore, the culture method is insensitive and has
a lower positivity rate due to various reasons including
the administration of antimicrobial therapy before clinical
sample collection and also the low count of causative agents
itself [1]. To make things worse, some of the causative agents
are very fastidious and require special transport and culture
media to grow [2].
Molecular approaches such as polymerase chain reaction
(PCR) based methods have become an important tool to
detect respiratory pathogens due to their superior sensitivity,
relatively faster turnaround time as compared to conventional
method, and the ability to identify pathogens that are growing
slowly or are difficult to culture. Both conventional and real-
time PCR assays have been developed to detect respiratory
pathogens [3–9]. However, real-time PCR does not appear
to offer advantages when testing a large number of samples
due to higher cost of equipment and reagents and the need
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of trained technical staff and controlled environment for
assay setups. In low resource laboratories, conventional PCR
have been widely used to detect such pathogens. However,
some of the limitations of conventional PCR are the risk
of contamination due to multiple pipetting steps, requiring
skilled personnel for master mix preparation, and cold-chain
transportation and storage. Thus, the clinical application of
these techniques in low resources and remote areas is limited
due to the need for well-trained personnel and the lack of
good facilities to store all required reagents and enzyme in
a specific temperature range [3].
In order to overcome the above-mentioned problems, a
thermostabilized, ready-to-use one-step PCR assay, which
require no cold-chain, was developed in this study for
simultaneous detection of K. pneumoniae and H. influenzae
in a single tube reaction. This technique only requires two
pipetting steps and thus may reduce the chance of cross-
contamination caused by multiple pipetting steps.
2. Materials and Methods
2.1. Clinical Samples and Clinical Isolates. Two reference bac-
terial strains used in this study were Haemophilus influenza
American Type Control Centre (ATCC 49247) and Klebsiella
pneumoniae (ATCC 1706). For the assessment of sensitivity
and specificity, a total of 127 clinical isolates from various
bacterial strains were obtained from the Department of
Medical Microbiology and Parasitology, School of Medical
Sciences, Universiti Sains Malaysia (Table 1), from January to
July 2015. All those clinical isolates were identified by VITEK
2 system (BioMe´rieux, France). The study was approved by
the Institutional Review Board of theHumanResearch Ethics
Committee, USM (HREC) IRB Reg No 00004494.
2.2. Primer Design. Two specific sets of primers were de-
signed based on the p6 gene of H. influenzae (582 bp) and
php gene of K. pneumoniae (202 bp) by using the Primer-
BLASTprogram (https://www.ncbi.nlm.nih.gov/tools/primer-
blast/). An internal control (IC) primer was designed based
on the glmM gene ofHelicobacter pylori (105 bp). This gene is
nonvirulent and genetically unrelated to both K. pneumoniae
and H. influenzae. The IC was incorporated in order to
verify the absence of PCR inhibitors that could lead to false-
negative results. The primers were synthesized by First Base
Laboratories, Singapore. Due to issues related to intellectual
property and patent, the full sequence of the reverse and
forward primers could not be revealed here.
2.3. DNA Extraction. TheDNAwas extracted from reference
bacterial strains and clinical isolates using a QIAamp DNA
Mini Kit (Qiagen, Germany), according to themanufacturer’s
instruction. The DNA concentration and purity were mea-
sured using a spectrophotometer (Eppendorf Biophotometer,
Germany), while the integrity of the extracted DNA was
tested using a FluoroSafe-stained agarose gel. Purified DNA
was kept at −20∘C until it was used.
2.4. Thermostabilization of PCR Reagents. Each PCR master
mix consisted of 1.25 pmol of each forward and reverse primer
for php and p6 genes, 2.5 pmol of each primer for IC, 1x
Taq Buffer (Axon Scientific, Malaysia), 1.5mMMgCl
2
(Axon
Scientific, Malaysia), 0.16mM of each of the dNTPs (Axon
Scientific, Malaysia), and 1.5U of Taq DNA Polymerase
(Axon Scientific, Malaysia) and 1 pg IC DNA template.
The positive control contained both DNA templates of
K. pneumoniae and H. influenzae that were added to the
mixture; meanwhile the negative control contained only IC.
Trehalose (Sigma-Aldrich, USA) was added as an enzyme
stabilizer in the PCR mixture and was subjected to a drying
process for 2 hours at 5.0−2mBar pressure using Heto vac-
uum concentrator (Heto Holten A/S, Denmark), which was
connected to a LyoLab 3000 freeze-dryer (Heto Holten A/S,
Denmark).Then, the thermostabilized PCR tubeswere stored
in a sealed aluminium pouch with desiccant at 4∘C, 25∘C, and
37∘C.
2.5. Optimization of Thermostabilized Multiplex Mixture
(Enzyme Stabilizer and Taq DNA Polymerase). Optimiza-
tion of thermostabilized multiplex PCR was carried out by
preparing the standardized multiplex mixture. The enzyme
stabilizer was added to thermostabilized PCR mixture in
order to preserve the Taq DNA polymerase enzyme activity.
In this study, the concentration of enzyme stabilizer was
optimized starting from 2 to 10%. The concentration of Taq
DNA polymerase should be in balance with the enzyme
stabilizer to make sure it works optimum and does not
influence the efficacy and sensitivity of the amplification
process. The concentration of Taq DNA polymerase was
optimized starting from 100 to 250%ofTaqDNApolymerase.
DNA templates ofH. influenzae andK. pneumoniae reference
strains were used as positive control.
2.6. Thermostabilized Multiplex PCR. The thermostabilized
multiplex PCR was performed by adding 18 𝜇l DNase-free
water and 2 𝜇l of the DNA template into a tube containing
thermostabilized PCR reagents. The mixture was vortexed
briefly to dissolve the dried pellets. Each of the negative
control tube received 20𝜇l DNase-free water. The PCR
amplification was done using a Gradient Cycler MJ Research
(MJ Research, USA) with one cycle of initial denaturation
at 95∘C for 5min, 30 cycles of denaturation, and annealing
and extension at 95∘C for 30 s, 60∘C for 30 s, and 72∘C for
30 s, respectively. This was followed by an extra annealing
temperature at 60∘C for 30 s and final extension at 72∘C for
3min.The amplified PCR products were analyzed using 1.5%
agarose gel electrophoresis, stained with FluoroSafe (First
Base, Singapore), and visualized under UV illuminator using
an image analyzer (ChemilImager 5500; Alpha Innotech, San
Leandro, CA, USA).
2.7. Evaluation of Sensitivity and Specificity of Thermostabi-
lized PCR. PurifiedDNA of reference strains ofH. influenzae
and K. pneumoniae were diluted to an undetectable level for
sensitivity determination.The sensitivity of thermostabilized
PCR was determined using extracted DNA from 20 clinical
isolates of each of H. influenzae and K. pneumoniae. Limit
detection (LOD) of thermostabilized multiplex PCR at the
bacterial level was determined using tenfold dilution starting
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Table 1: Bacterial species and strains used in this study and results of the thermostabilized mPCR.
No Reference strains Php (202 bp) P6 (582 bp) Internal control (IC)
(1) Klebsiella pneumoniae (ATCC 1706)a + − +
(2) Klebsiella pneumoniae (𝑛 = 20)b + − +
(3) Haemophilus influenzae (ATCC 49247)a − + +
(4) Haemophilus influenzae (𝑛 = 20)b − + +
Gram negative bacteria
(5) Pseudomonas aeruginosa (𝑛 = 15)b − − +
(6) Escherichia coli (EHEC) (𝑛 = 6)b − − +
(7) E. coli (ETEC) (𝑛 = 1)b − − +
(8) Shigella sonnei (𝑛 = 1)b − − +
(9) Shigella flexneri (𝑛 = 1)b − − +
(10) Shigella boydii (𝑛 = 1)b − − +
(11) Shigella dysenteriae (𝑛 = 1)b − − +
(12) Salmonella typhi (𝑛 = 1)b − − +
(13) Vibrio cholerae (𝑛 = 1)b − − +
(14) Citrobacter freundii (𝑛 = 1)b − − +
(15) Acinetobacter baumannii (𝑛 = 1)b − − +
(16) Acinetobacter spp.(𝑛 = 1)b − − +
(17) Klebsiella spp.(𝑛 = 3)b − − +
(18) Haemophilus parainfluenzae (𝑛 = 2)b − − +
(19) Proteus mirabilis (𝑛 = 1)b − − +
(20) Burkholderia pseudomallei (𝑛 = 1)b − − +
(21) Moraxella catarrhalis (𝑛 = 1)b − − +
(22) Citrobacter spp.(𝑛 = 1)b − − +
(23) Mycobacterium tuberculosis (𝑛 = 6)b − − +
(24) Mycobacterium bovis (𝑛 = 1)b − − +
Gram positive bacteria
(25) Listeria monocytogenes (𝑛 = 1)b − − +
(26) Staphylococcus aureus (𝑛 = 25)b − − +
(27) Methicillin Resistant Staphylococcus aureus (MRSA) (𝑛 = 7)b − − +
(28) Streptococcus viridians (𝑛 = 1)b − − +
(29) Streptococcus pneumoniae (𝑛 = 1)b − − +
(30) Streptococcus pyogenes (𝑛 = 1)b − − +
(31) Streptococcus Group A (𝑛 = 1)b − − +
(32) Streptococcus Group B (𝑛 = 1)b − − +
(33) Streptococcus Group G (𝑛 = 1)b − − +
(34) Bacillus subtilis (𝑛 = 1)b − − +
aReference strains from America Type Control Center (ATCC), USA.
bDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia.
from 105 CFU/ml to 101 CFU/ml. Bacteria cells of both bac-
teria were grown in BHI broth, extracted by boiling method
at 100∘C, and used as a template in the assay. The specificity
of thermostabilized PCR was also evaluated using extracted
DNA from 47 clinical isolates of Gram-negative bacteria and
40 clinical isolates of Grampositive bacteria that are normally
found in the respiratory tract.
2.8. Evaluation of Stability of Thermostabilized PCR. The
stability or shelf life of the thermostabilized PCR assay was
estimated using the Q10 accelerated aging technique, as
described by Clark, 1991 [9].The thermostabilized PCR tubes
were stored under elevated temperatures of 4∘C, 25∘C, and
37∘C up to 30 days and were tested periodically.The duration
of thermostabilized PCR was then calculated to estimate its
stability at 37∘C.
3. Results
3.1. Multiplex PCR. The multiplex PCR was optimized and
standardizedwith the reference strains ofH. influenzae andK.
pneumoniae. As shown in Figure 1, the multiplex PCR assay
successfully amplified p6 gene of H. influenzae (582 bp), php
gene of K. pneumoniae (202 bp), and glmM gene of H. pylori












Figure 1: Representative agarose gel electrophoresis of themultiplex
PCR using reference strains of H. influenzae and K. pneumoniae.
Lane M: 100 bp DNA ladder (Fermentas, USA); Lane 1: negative
control (IC); Lane 2: PCR amplicon of K. pneumoniae; Lane 3: PCR
amplicon of H. influenzae; Lane 4: PCR amplicons of multiplex
PCR (K. pneumoniae + H. influenzae); Lane 5: PCR amplicons of
multiplex PCR (IC + K. pneumoniae + H. influenzae).
(105 bp).The PCR assay was positive forK. pneumoniaewhen
php gene (202 bp) and IC (105 bp) were present. Meanwhile,
the PCR assay was positive for H. influenzae when p6 gene
(582 bp) and IC (105 bp) were detected. The multiplex PCR
was considered as valid negative when only IC (105 bp) was
observed.
3.2. Optimization of Thermostabilized Multiplex Mixture
(Enzyme Stabilizer and Taq DNA Polymerase). Both con-
centrations of enzyme stabilizer and Taq DNA polymerase
should be in balance in order to make Taq DNA polymerase
work at optimum phase. As shown in Figures 2 and 3, 8%
of trehalose with 200% (1.5U) of Taq DNA polymerase pro-
duced similar band intensities before and after lyophilization
process. Therefore, this mixture was selected as the optimal
concentration for thermostabilization process.
3.3. Evaluation of Analytical Sensitivity of Thermostabilized
PCR. To evaluate analytical sensitivity of the thermostabi-
lized PCR, we tested the assay with clinical isolates of K.
pneumoniae (𝑛 = 20) and H. influenzae (𝑛 = 20) which
was previously confirmed by VITEK 2 system (BioMe´rieux,
France). As shown in Figures 4 and 5, the PCR assay success-
fully amplified all strains ofK. pneumoniae andH. influenzae,
respectively. The detection limit of the assay was determined
by using 10-fold serial dilutions starting from 105 CFU/ml
to 101 CFU/ml. As shown in Figure 6, the detection limit of
multiplex PCR was 104 CFU/ml.
3.4. Evaluation of Analytical Specificity of Thermostabilized
PCR. To verify the analytical specificity of thermostabilized
PCR assay, clinical isolates from various bacterial species
were tested.The thermostabilizedmultiplex PCR successfully
amplified H. influenzae (582 bp), K. pneumoniae (202 bp),
and IC (105 bp). All other bacterial species were negative, and
this demonstrates that no cross-reactivity occurred (Table 1).
The analytical specificity of the thermostabilized, one-step,
PCR assay was 100%.
3.5. Evaluation of Stability of Thermostabilized PCR. Eval-
uation of thermostabilized multiplex PCR stability was
determined by time and through accelerated aging test using
heat. As shown in Figures 7(a) and 7(b), the thermostabilized
was shown to be stable up to 1month at all temperature values.
Based on the band intensities, accelerated stability aging test
was used to calculate the shelf life at temperature 37∘C. Accel-
erated stability calculation was performed using estimated
shelf life based on conservative standard accelerated aging
factor. At elevated temperature of 37∘C, the thermostabilized
multiplex PCR mixture was stable up to 30 days, indicating
the following.
The longest duration that the thermostabilized PCR
maintained its activity was calculated as described by Clark,
1991 [9]:
Age of the thermostabilized PCR tubes = 1.0 months
at 37∘C.
Ambient temperature RT = 25∘C.
𝑄10 = 1.8.
Acceleration factor at 37∘C (based on 12∘C tempera-
ture difference): (1.8)1.2 = 2.02.
Length of time at elevated temperature: 1.0 month.
Estimation of shelf life:
accelerated age = age × acceleration factor (at 37∘C),
1.0 months × 2.02 = 2.02months,
shelf life = accelerated age + actual age,
2.02 + 1.0 = 3.02months.
4. Discussion
Conventional culture method of bacterial identification
becomes the gold standard in laboratories. However, this
conventional method is time consuming, laborious, and less
sensitive [4, 5]. There are a lot of factors that may influence
the culture results, including antimicrobial treatment, pro-
longed transportation time, and inappropriate transportation
medium [5, 6]. Due to these limitations, the need to utilize
more sensitive methods such as multiplex PCR, real-time
PCR, and microarray assays are now greatly increased.These
approaches provide faster speed and greater sensitivity in the
identification of bacteria, especially respiratory pathogens.
Detection of H. influenzae and K. pneumoniae by real-time
PCR and microarray has been developed to increase the
chances of detection rates and the accuracy of quantification
[7–9]. However, there are some challenges that limit the
widespread application of PCR such as the lack of cold-
chain-free PCR assay, well-trained staffs to reduce the risk of
contamination, instrument availability, and good facilities to
store all required reagents and enzyme in a specific temper-
ature range [10]. Lyophilization of PCR assays can overcome
some of these limitations and enable widespread application
of PCR in low resource setting. This study describes the
development of a lyophilized, cold-chain-free PCR assay for
detection of H. influenzae and K. pneumoniae in single tube
reaction.
In our study, the primers were designed to amplify php
gene ofK. pneumoniae and p6 gene ofH. influenzae. Php gene
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Figure 2: Effect of different concentrations of trehalose on the performance of thermostabilized multiplex PCR. (a) 2% stabilizer. (b) 4%
stabilizer. (c) 6% stabilizer. (d) 8% stabilizer. (e) 10% stabilizer. Lane M: 100 bp DNA ladder (Fermentas, USA); Lane 1: negative control
before lyophilization (IC); Lane 2: positive control before lyophilization (IC + K. pneumoniae + H. influenzae); Lane 3: negative control after
lyophilization (IC); Lane 4: positive control after lyophilization (IC + K. pneumoniae + H. influenzae).
was chosen due to its ability to differentiate K. pneumoniae
and K. varicella. Meanwhile, p6, the gene that encodes the
outer membrane protein, is present in all strains of H.
influenzae and is able to detect both typeable and nontypeable
H. influenza. An IC primer was designed based on the glmM
gene of H. pylori, which is genetically unrelated to both
K. pneumoniae and H. influenzae. The IC was incorporated
in order to ensure the result’s validity and to identify PCR
inhibitory factors [11]. Lyophilization of PCR assay has
many advantages and is important in mitigating some of
the PCR limitations. In the present study, the developed
multiplex PCR assay was then lyophilized into a ready-to-
use format which contains all reagents for PCR reactions,
including primers and Taq DNA polymerase, requiring only
the addition of water and extracted sample for analysis. Two
parameters (enzyme stabilizer and Taq DNA polymerase)
were optimized during this process. Trehalose was added as
an enzyme stabilizer to protect and prevent any conformation
changes of Taq DNA polymerase enzyme during and after
dehydration [11, 12]. It stabilizes the PCR reagents, especially
Taq DNA polymerase against stresses brought by vacuum
drying and freeze thawing [13]. The presence of glycerol
may affect the product’s stability. The improved sensitivity
observed in lyophilized assay can be explained by the fact
that when developing these assays, the Taq DNA polymerase
used is glycerol-free.This allows higher concentrations ofTaq
DNA polymerase to be used per reaction in the lyophilized
assay than in the nonlyophilized assay [14]. The intensities of
bands were found to be increasing from 2 to 10% stabilizer.
Hence, enzyme stabilizer at the concentration of 8% was
chosen in this study since it gives almost the same band
intensities before and after lyophilization. All bands showed
uniform amplicon intensities at Taq DNA concentration
of 200%. Lower concentration of Taq DNA polymerase
gave less band intensities and may affect the efficacy and
specificity of amplification process [11]. Based on the results
obtained, the optimum conditions of thermostabilized PCR
were determined at 8% enzyme stabilizer and 200% TaqDNA
polymerase.
The sensitivity and specificity performances of ther-
mostabilizedmultiplex PCR were evaluated using 127 clinical
isolates from various bacteria strains. Among 120 isolates,
20 isolates were identified as H. influenzae and 20 others
were identified as K. pneumoniae.The specificity of the assay
was assessed by testing a panel of other bacterial species
which were previously identified using VITEK 2 system
(BioMe´rieux, France) (Table 1). All non-H. influenzae and
non-K. pneumoniae showed negative results where only IC
amplicon was detected. An overall analysis of the multiplex
PCR showed 100% sensitivity and specificity. The detection
limit of thermostabilized multiplex PCR for H. influenzae
and K. pneumoniae at bacteria level was at 1.0 × 103 CFU/ml,
whereas the sensitivity of bothmultiplex PCR assayswas at 1.0
× 104 CFU/ml.The sensitivity level achieved in this study was
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Figure 3: Effect of different concentrations of Taq DNA polymerase on the performance of thermostabilized multiplex PCR. (a) 100%
Taq DNA polymerase. (b) 150% Taq DNA polymerase. (c) 200% Taq DNA polymerase. (d) 250% Taq DNA polymerase. Lane M: 100 bp
DNA ladder (Fermentas, USA); Lane 1: negative control before lyophilization (IC); Lane 2: positive control before lyophilization (IC +
K. pneumoniae + H. influenzae); Lane 3: negative control after lyophilization (IC); Lane 4: positive control after lyophilization (IC + K.
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Figure 4: Representative agarose gel electrophoresis of thermostabi-
lizedmultiplex PCR ofK. pneumoniae strains. Lane: M, 100 bp DNA
ladder (Fermentas, USA); N, negative control; 1, K. pneumoniae
(ATCC 1706); 2–10, clinical isolates of K. pneumoniae.
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Figure 5: Representative agarose gel electrophoresis of thermosta-
bilized multiplex PCR of H. influenzae strains. Lane: M, 100 bp
DNA ladder (Fermentas, USA); N: negative control, 1:H. influenzae









Figure 6: Analytical sensitivity of thermostabilized multiplex PCR
at bacterial level for H. influenzae and K. pneumoniae. Lane: M,
100 bp DNA ladder (Fermentas, USA); N, negative control (IC); 1,
positive control (IC+K. pneumoniae+H. influenzae); 2, 105 CFU/ml
lysate of H. influenzae and K. pneumoniae; 3, 104 CFU/ml lysate
of H. influenzae and K. pneumoniae; 4, 103 CFU/ml lysate of H.
influenzae and K. pneumoniae; 5, 102 CFU/ml lysate ofH. influenzae
and K. pneumoniae; 6, 101 CFU/ml lysate of H. influenzae and K.
pneumoniae.























































Figure 7: (a) Accelerated stability evaluation at Day 0 storage of test at different temperatures. (A) 4∘C. (B) 25∘C. (C) 37∘C. Lane M: 100 bp
DNA ladder (Fermentas, USA); Lane 1: negative control (before thermostabilization); Lane 2: positive control (before thermostabilization);
Lane 3: negative control (after thermostabilization); Lane 4: positive control (after thermostabilization). (b) Accelerated stability evaluation
of test at different temperatures and storage periods. (A) Day 7. (B) Day 14. (C) Day 30. Lane M: 100 bp DNA ladder (Fermentas, USA); Lane
1: negative control at 4∘C; Lane 2: positive control at 4∘C; Lane 3: negative control at 25∘C; Lane 4: positive control at 25∘C; Lane 5: negative
control at 37∘C; Lane 6: positive control at 37∘C.
found to be comparable to the ones obtained in prior studies
[3, 11, 12].
Using the Q10 method, the stability of the PCR assay
was estimated using accelerated aging techniques at elevated
temperature and monitoring stability overtime. The longest
duration that the thermostabilized PCRmaintains its activity
is calculated to determine the shelf life of the assay [14].
The stability of thermostabilized PCR assay was tested by
comparing the performance of assay at three different tem-
peratures (4∘C, 25∘C, and 37∘C) over a period of 30 days
(estimated 1 month), tested at seven-day intervals. Based on
the results, thermostabilizedmultiplex PCRwas stable at 37∘C
of elevated temperature for 30 days and, from calculation,
3.02 months (conservative calculation) when kept at 37∘C.
The stability of PCR assay demonstrated that the assay can be
transported and stored without the need for cold-chain and
being concerned towards the degradation of reagents or low
test reliability.
5. Conclusion
The thermostabilized, ready-to-use, cold-chain-free, multi-
plex PCR was successfully developed for simple, rapid, and
simultaneous detection of H. influenzae and K. pneumoniae.
Thismethod requires only two pipetting steps and has simple
workflow and very low risk of contamination and is stable at
room temperature.
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